Nasopharyngeal carcinoma: a review

Seminars in Diagnostic Pathology
Fredrik Petersson

Abstract

Nasopharyngeal carcinoma is an umbrella term for a group of malignant epithelial tumors with different etiopathogenesis and a broad range of histopathological appearances. Some types have a dramatically skewed geographical and ethnic distribution and shows virtually 100% association with Epstein Barr virus. The field of other/contributing etiological factors are only partially known and recently a subset of this carcinoma has been linked to transcriptionally active Human Papilloma virus. As with all malignant tumors, the clinical stage of disease is of paramount importance. Despite loco-regionally advanced disease, a large proportion of these patients respond well to radiotherapy, either alone or in combination with chemotherapy and long term sequelae including, but not limited to, development of secondary, radiation-induced malignant tumors is a real clinical problem. This review attempts to provide the practicing pathologist with an overview of nasopharyngeal carcinoma and recent advances in the multifaceted understanding of this group of neoplasms. In addition, some information on prognosis, staging, treatment and treatment related complications in this group of patients is provided.

References

Jan 15, 1976·International Journal of Cancer. Journal International Du Cancer·G Henle, W Henle
May 1, 1992·Journal of Clinical Pathology·P DickensY T Liu
Oct 21, 1992·International Journal of Cancer. Journal International Du Cancer·R D BurtB McKnight
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·C A PerezN Kucik
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K GilliganN Raab-Traub
Jan 1, 1990·The British Journal of Radiology·J S Sham, D Choy
Jun 1, 1990·Cancer·J S ShamD Choy
Jun 15, 1990·International Journal of Cancer. Journal International Du Cancer·M C YuB E Henderson
Jun 15, 1989·International Journal of Cancer. Journal International Du Cancer·M C YuB E Henderson
Jan 15, 1987·International Journal of Cancer. Journal International Du Cancer·N Raab-TraubJ Pagano
Aug 1, 1986·American Journal of Clinical Oncology·A D FloresP Coy
Feb 1, 1973·The New England Journal of Medicine·G MillerL L Andrews
Aug 22, 1973·Nature: New Biology·H WolfV Becker
Nov 15, 1967·International Journal of Cancer. Journal International Du Cancer·K ShanmugaratnamK W Lee
Sep 1, 1984·The Annals of Otology, Rhinology, and Laryngology·H B NeelW F Taylor
Feb 15, 1982·International Journal of Cancer. Journal International Du Cancer·Y ZengG R Su
Dec 15, 1980·International Journal of Cancer. Journal International Du Cancer·P H LevineJ M Easton
Jan 1, 1981·Preventive Medicine·M C YuB E Henderson
Apr 1, 1981·Food and Cosmetics Toxicology·D P HuangT A Gough
Apr 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S C Huang
Mar 1, 1995·American Journal of Otolaryngology·S P ReddyJ E Marks
Oct 15, 1994·International Journal of Cancer. Journal International Du Cancer·X N ZouB Liu
Dec 1, 1994·International Journal of Cancer. Journal International Du Cancer·H P LeeN E Day
Dec 15, 1994·International Journal of Cancer. Journal International Du Cancer·M L LungT L Phillips
Jan 15, 1994·International Journal of Cancer. Journal International Du Cancer·S Kripalani-Joshi, H Y Law
Jan 2, 1993·International Journal of Cancer. Journal International Du Cancer·Q L LuJ A Thomas
Sep 1, 1996·International Journal of Radiation Oncology, Biology, Physics·P TeoP J Johnson
Apr 1, 1997·The Annals of Otology, Rhinology, and Laryngology·M A VasefL M Weiss
Aug 20, 1997·Journal of the National Cancer Institute·A HildesheimS K Chhabra
Feb 18, 1998·International Journal of Cancer. Journal International Du Cancer·V GrunewaldI Joab
Apr 16, 1998·International Journal of Cancer. Journal International Du Cancer·N S SungN Raab-Traub
May 14, 1998·International Journal of Cancer. Journal International Du Cancer·S T CheungD P Huang

❮ Previous
Next ❯

Citations

Sep 18, 2015·Cancer Medicine·Vidya VedhamSomdat Mahabir
Apr 14, 2016·Trends in Microbiology·Deilson Elgui de OliveiraJoseph S Pagano
Sep 21, 2016·Mediators of Inflammation·Shumin WangMariko Murata
Feb 16, 2017·Clinical and Experimental Pharmacology & Physiology·Wan-Le MaCheng-Xian Guo
Feb 26, 2016·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Charles A RileyEdward D McCoul
Sep 15, 2018·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Sai D ChallapalliNosayaba Osazuwa-Peters
Oct 24, 2019·Pediatric Research·Henry H BalfourJennifer M Grimm-Geris
Nov 2, 2016·Oncotarget·Xiuhua LiHongjiao Li
May 21, 2020·International Journal of Surgical Pathology·Maria MostykaMeredith E Pittman
Aug 31, 2020·Ear, Nose, & Throat Journal·Vidal A VillelaEnrique Palacios
Oct 31, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Vui Heng ChongChee Fui Chong
Jan 5, 2017·Genes and Environment : the Official Journal of the Japanese Environmental Mutagen Society·Shosuke KawanishiMariko Murata
Jun 19, 2019·British Journal of Biomedical Science·J Yin, S S Zhu
Dec 14, 2018·Head and Neck Pathology·Fredrik Petersson
May 2, 2020·International Journal of Molecular Sciences·Maria Manuel AzevedoFátima Baltazar
Jul 19, 2016·The American Journal of Nursing·Janet McKiernan, Bridgette Thom
Sep 16, 2017·Experimental and Therapeutic Medicine·Dong-Shu Zheng, Liang-Shu Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis